Cargando…

The role of BRCA1/2 in hereditary and familial breast and ovarian cancers

BACKGROUND: BRCA1/2 pathogenic variants have become associated with familial breast and ovarian cancers, and hereditary cancer‐predisposition syndrome. With advances in molecular biology, BRCA profiling facilitates early diagnosis and the implementation of preventive and therapeutic strategies. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hawsawi, Yousef M., Al‐Numair, Nouf S., Sobahy, Turki M., Al‐Ajmi, Areej M., Al‐Harbi, Raneem M., Baghdadi, Mohammed A., Oyouni, Atif A., Alamer, Osama M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732305/ https://www.ncbi.nlm.nih.gov/pubmed/31317679 http://dx.doi.org/10.1002/mgg3.879

Ejemplares similares

Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows
por: Sobahy, Turki M., et al.
Publicado: (2022)

Camels’ biological fluids contained nanobodies: promising avenue in cancer therapy
por: Al-Numair, Nouf S., et al.
Publicado: (2022)

Correction: Camels’ biological fluids contained nanobodies: promising avenue in cancer therapy
por: Al‑Numair, Nouf S., et al.
Publicado: (2023)

Stem Cell Applications for Treatment of Cancer and Autoimmune Diseases: Its Promises, Obstacles, and Future Perspectives
por: Hawsawi, Yousef M., et al.
Publicado: (2018)

Prostate cancer and therapeutic challenges
por: Hawsawi, Yousef MohammedRabaa, et al.
Publicado: (2020)

Oriental Hornet (Vespa orientalis) Larval Extracts Induce Antiproliferative, Antioxidant, Anti-Inflammatory, and Anti-Migratory Effects on MCF7 Cells
por: Zedan, Amina M. G., et al.
Publicado: (2021)

Novel sequence variants in the TLR6 gene associated with advanced breast cancer risk in the Saudi Arabian population
por: Semlali, Abdelhabib, et al.
Publicado: (2018)

CACSV: a computational web-sever that provides classification for cancer somatic genetic variants from different tissues
por: AlKurabi, Nahla, et al.
Publicado: (2023)

Biweekly cetuximab in combination with capecitabine and oxaliplatin (XELOX) or irinotecan (XELIRI) in the first-line and second-line treatment of patients with RAS wild-type metastatic colorectal cancer
por: Zekri, Jamal, et al.
Publicado: (2022)

DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas
por: Kamieniak, M M, et al.
Publicado: (2013)

Potential role of Toll-like receptor 2 expression and polymorphisms in colon cancer susceptibility in the Saudi Arabian population
por: Semlali, Abdelhabib, et al.
Publicado: (2018)

Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer
por: Buleje, Jose, et al.
Publicado: (2017)

High prevalence of iron deficiency anemia in infants attending a well-baby clinic in northwestern Saudi Arabia
por: Hawsawi, Zakaria M. Al, et al.
Publicado: (2015)

Antiapoptotic Gene Genotype and Allele Variations and the Risk of Lymphoma
por: Al-Amer, Osama M., et al.
Publicado: (2023)

Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2
por: Samuel, David, et al.
Publicado: (2022)

Association of HER1 and HER2 Gene Variants in the Predisposition of Colorectal Cancer
por: Alanazi, Ibrahim O., et al.
Publicado: (2021)

Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes
por: Toss, Angela, et al.
Publicado: (2015)

Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis
por: Abdulrashid, Khadiga, et al.
Publicado: (2019)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Ewald, Ingrid Petroni, et al.
Publicado: (2016)

The SAAP pipeline and database: tools to analyze the impact and predict the pathogenicity of mutations
por: Al-Numair, Nouf S, et al.
Publicado: (2013)

New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy
por: Theyab, Abdulrahman, et al.
Publicado: (2023)

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
por: NOVAKOVIĆ, SRDJAN, et al.
Publicado: (2012)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
por: Cipollini, G., et al.
Publicado: (1999)

BRCA1 Norway: comparison of classification for BRCA1 germline variants detected in families with suspected hereditary breast and ovarian cancer between different laboratories
por: Hovland, Henrikke N., et al.
Publicado: (2022)

Awareness of basic life support and cardiopulmonary resuscitation among female secondary school students in government schools in Riyadh city, KSA
por: Al Harbi, Nouf, et al.
Publicado: (2018)

Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients
por: Jarhelle, Elisabeth, et al.
Publicado: (2019)

Persistent Idiopathic Mirror Writing in a Right-Handed Healthy Young Woman: A Case Report
por: AlAmer, Naheel A., et al.
Publicado: (2020)

Whole‐exome sequencing of non‐BRCA1/BRCA2 mutation carrier cases at high‐risk for hereditary breast/ovarian cancer
por: Felicio, Paula S., et al.
Publicado: (2020)

Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family
por: Liao, Ying, et al.
Publicado: (2020)

MicroRNA-126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated BRCA1
por: Al-Showimi, Maram, et al.
Publicado: (2022)

Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
por: Digennaro, M., et al.
Publicado: (2017)

BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk
por: Kwiatkowski, Fabrice, et al.
Publicado: (2015)

Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
por: Piombino, Claudia, et al.
Publicado: (2020)

The association of metformin use with vitamin B12 deficiency and peripheral neuropathy in Saudi individuals with type 2 diabetes mellitus
por: Alharbi, Turki J., et al.
Publicado: (2018)

Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain)
por: Ruiz de Sabando, Ainara, et al.
Publicado: (2019)

Endocrowns: Indications, Preparation Techniques, and Material Selection
por: AlDabeeb, Dalal S, et al.
Publicado: (2023)

Endovascular repair of severe aortic coarctation, transcatheter aortic valve replacement for severe aortic stenosis, and percutaneous coronary intervention in an elderly patient with long term follow-up
por: Fallatah, Raneem, et al.
Publicado: (2018)

Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)
por: Blay, Pilar, et al.
Publicado: (2013)

BARD1 mystery: tumor suppressors are cancer susceptibility genes
por: Hawsawi, Yousef M., et al.
Publicado: (2022)

Clinical characteristics, risk factors, and rate of severity of a nationwide COVID-19 Saudi cohort
por: Al-Numair, Nouf S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r3e78idmd8cqgs6ne6cmn9j8hq